Correlation Between Senti Biosciences and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Senti Biosciences and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Senti Biosciences and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Senti Biosciences and DiaMedica Therapeutics, you can compare the effects of market volatilities on Senti Biosciences and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Senti Biosciences with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Senti Biosciences and DiaMedica Therapeutics.
Diversification Opportunities for Senti Biosciences and DiaMedica Therapeutics
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Senti and DiaMedica is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Senti Biosciences and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Senti Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Senti Biosciences are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Senti Biosciences i.e., Senti Biosciences and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Senti Biosciences and DiaMedica Therapeutics
Given the investment horizon of 90 days Senti Biosciences is expected to under-perform the DiaMedica Therapeutics. In addition to that, Senti Biosciences is 1.67 times more volatile than DiaMedica Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. DiaMedica Therapeutics is currently generating about 0.12 per unit of volatility. If you would invest 290.00 in DiaMedica Therapeutics on August 29, 2024 and sell it today you would earn a total of 231.00 from holding DiaMedica Therapeutics or generate 79.66% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Senti Biosciences vs. DiaMedica Therapeutics
Performance |
Timeline |
Senti Biosciences |
DiaMedica Therapeutics |
Senti Biosciences and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Senti Biosciences and DiaMedica Therapeutics
The main advantage of trading using opposite Senti Biosciences and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Senti Biosciences position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |